Chimeric extracellular domain of type II transforming growth factor (TGF)‐β receptor fused to the Fc region of human immunoglobulin as a TGF‐β antagonist
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Transforming growth factor‐β (TGF‐β) type‐I and type‐II receptors form a ligand‐dependent heteromeric signalling complexes, in which transforming growth factor‐β receptor type II (TβRII) trends to act as the primary receptor. In the present study, we used a chimeric soluble type‐II receptor fused with the Fc regions of human immunoglobulin (TβRIIs‐Fc) in order to obtain a putative TGF‐β antagonist. Biochemical studies revealed that TβRIIs‐Fc shared the same properties as the wild‐type receptor. The TβRIIs‐Fc receptor displayed an affinity of 1370 ± 363 pM which was similar to those of the wild‐type TβRII when expressed alone in Cos‐1 cells (1122 ± 413 pM). Furthermore, the chimeric receptor showed the same selectivity for TGF‐β isoforms as the native receptor. Although both TGF‐β1 and TGF‐β3 were able to bind TβRIIs‐Fc, TGF‐β2 could not compete with the binding of TGF‐β1 to TβRIIs‐Fc. It was noted that this type of fused Fc receptor could be used in FlashPlate screening for potent agonism and antagonism of TGFβ. Moreover, biological activities of the chimeric receptor showed it to be a potent TGF‐β1‐antiproliferative and TGF‐β1‐extracellular matrix transcriptional inhibitor on responses in Mv1Lu cells. To conclude, our results clearly show that the TβRIIs‐Fc chimeric receptor could be used as a potent TGF‐β antagonist. These data raised the possibility that this TβRIIs‐Fc construct might act successfully as an antagonist of both TGF‐β1 and TGF‐β3 in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Broekelmann, T. J., Limper, A. H., Colby, T. V., & McDonald, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6642 · Cited by 794
Cited by
Alpha-Smooth Muscle Actin Expression Upregulates Fibroblast Contractile Activity
Hinz, B., Celetta, G., Tomasek, J. J., Gabbiani, G., & Chaponnier, C. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.9.2730 · Cited by 1,288
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
Guilliams, M., Bonnardel, J., Haest, B., Vanderborght, B., Wagner, C., Remmerie, A., Bujko, A., Martens, L., Thoné, T., Browaeys, R., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.018 · Cited by 985
“, 2021), while TGFbRII-Fc selectively interferes with TGFb1/TGF-b3 receptor binding (Komesli et al., 2017).”
BackgroundHinz, B., Mastrangelo, D., Iselin, C. E., Chaponnier, C., & Gabbiani, G. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61776-2 · Cited by 640
Branton, M. H., & Kopp, J. B. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00250-6 · Cited by 603
Yang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215333 · Cited by 404
Metadata
- Authors
- Komesli, S., Vivien, D., & Dutartre, P.
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 1998-06-15
- Volume
- 254
- Issue
- 3
- Pages
- 505-513
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W2018075165
- Cited by
- 63
- References
- 1
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chimeric extracellular domain of type II transforming growth factor (TGF)‐β receptor fused to the Fc region of human immunoglobulin as a TGF‐β antagonist. https://app.cochat.ai/papers/10.1046/j.1432-1327.1998.2540505.x
- The paper
- Komesli, S., Vivien, D., & Dutartre, P. (1998). Chimeric extracellular domain of type II transforming growth factor (TGF)‐β receptor fused to the Fc region of human immunoglobulin as a TGF‐β antagonist. European Journal of Biochemistry. https://doi.org/10.1046/j.1432-1327.1998.2540505.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.